A study in humans demonstrated that the mir-6873-3p was upregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention, showing significant differential expression after false-discovery rate correction [Onuoha et al. DOI:10.1111/cts.13307].